These health-tech veterans want to avert the next Theranos disaster with 'medical diligence'

Ruby Gadelrab and Jill Hagenkord are hoping to bridge the gap between technology and medicine, and help investors vet start-ups for potential red flags.

from Tech https://ift.tt/2GZRiOF